Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bowel Necrosis”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)Ended earlyNCT04433546
What this trial is testing

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirusHypoxic Respiratory Failure+15 more
PhaseBio Pharmaceuticals Inc. 54
Not applicableEnded earlyNCT00561548
What this trial is testing

Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease

Who this might be right for
Crohn Disease
Centre Hospitalier Universitaire de Nice 20
Post-approval studies (Phase 4)Enrolling By InvitationNCT04646187
What this trial is testing

De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseColitis, Ulcerative
University Medical Center Groningen 148
Testing effectiveness (Phase 2)Study completedNCT01714726
What this trial is testing

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

Who this might be right for
Crohn's Disease
AstraZeneca 121
Testing effectiveness (Phase 2)Active Not RecruitingNCT05185947
What this trial is testing

Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer

Who this might be right for
Gynecologic CancerGynecologic NeoplasmsPeritoneal Carcinomatosis+7 more
National Cancer Institute (NCI) 19
Not applicableLooking for participantsNCT07173062
What this trial is testing

Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome

Who this might be right for
StrokeCoronary Arterial Disease (CAD)Myocardial Infarction (MI)+4 more
Universidade do Porto 150
Not applicableUnknownNCT01388257
What this trial is testing

Anal Crohn Fistula Surgery

Who this might be right for
Crohn DiseaseFistulaAnoperineal Fistula+1 more
French Society of Coloproctology 180
Not applicableStudy completedNCT03090139
What this trial is testing

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets

Who this might be right for
Colitis, UlcerativeCrohn DiseaseInflammatory Bowel Diseases
Takeda 1,731
Large-scale testing (Phase 3)Study completedNCT01369329
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Who this might be right for
Crohn's DiseaseIBDColitis+1 more
Janssen Research & Development, LLC 769
Large-scale testing (Phase 3)Study completedNCT02165215
What this trial is testing

The Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Colitis, Ulcerative
Hoffmann-La Roche 359
Post-approval studies (Phase 4)Study completedNCT02349594
What this trial is testing

Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease

Who this might be right for
Crohn Disease
Radboud University Medical Center 6
Not applicableStudy completedNCT02054533
What this trial is testing

Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Icahn School of Medicine at Mount Sinai 974
Testing effectiveness (Phase 2)Study completedNCT02538341
What this trial is testing

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

Who this might be right for
Rheumatoid ArthritisInflammatory ArthritisArthritis+5 more
University of Alabama at Birmingham 617
Not applicableStudy completedNCT07263464
What this trial is testing

The Association Between TNFSF4 Polymorphism and CD

Who this might be right for
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)Polymorphism, Single NucleotideUstekinumab
Second Affiliated Hospital of Wenzhou Medical University 818
Early research (Phase 1)Ended earlyNCT00358397
What this trial is testing

One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy

Who this might be right for
Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Large-scale testing (Phase 3)Study completedNCT00552058
What this trial is testing

Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

Who this might be right for
Crohn Disease
UCB Pharma 439
Not applicableStudy completedNCT00782366
What this trial is testing

Predictive Genetic Risk Assessment Trial

Who this might be right for
Colon CancerLung CancerAtrial Fibrillation+8 more
Mayo Clinic 26
Large-scale testing (Phase 3)Study completedNCT00333788
What this trial is testing

Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
UCB Pharma 233
Post-approval studies (Phase 4)UnknownNCT02186886
What this trial is testing

Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab

Who this might be right for
Ulcerative Colitis
Kliniken im Naturpark Altmuehltal 50
Not applicableStudy completedNCT02376478
What this trial is testing

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

Who this might be right for
PsoriasisInflammatory Bowel Diseases
Medical University of Vienna 222
Load More Results